| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $2.36B | +9.7% |
| Cost of Revenue | $677.3M | +11.1% |
| Gross Profit | $1.69B | +9.1% |
| R&D Expense | $629.0M | +20.9% |
| SG&A Expense | $246.5M | +13.3% |
| Operating Income | $429.3M | -6.5% |
| Pre-tax Income | $588.0M | +15.5% |
| Income Tax | $62.3M | +191.3% |
| Net Income | $525.7M |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $703.5M | -20.6% |
| Accounts Receivable | $852.2M | +21.2% |
| Current Assets | $5.00B | +26.0% |
| Total Assets | $5.91B | +23.0% |
| Current Liabilities | $1.18B | +17.1% |
| Total Liabilities | $1.27B | +16.4% |
| Stockholders' Equity | $4.64B | +25.0% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $911.3M | +16.8% |
| Investing Cash Flow | -$1.08B | -6.8% |
| Financing Cash Flow | -$16.2M | +16.5% |
| +7.8% |
| EPS (Basic) | $3.27 | +4.1% |
| EPS (Diluted) | $3.22 | +7.3% |